4Culley CL, Kiang TK, Gilchrist SE, et al. Effect of the UGT1 A1 * 28 allele on unconjugated hyperbilirubinemia in HIV - positive pa- tients receiving Atazanavir: a systematic review [ J ]. Ann Pharmacother,2013,47 (4) :561 - 572.
5Bhutani VK, Stark AR, Lazzeroni LC, et al. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy [ J ]. J Pediatr,2013,162 ( 3 ) :477 - 482.
6Moyle G,Else L,Jackson A,et al. Co- administration of atazana- vir/ritonavir and zinc sulphate:impact on hyperbilirubinemia and pharmacokinetics [ J ]. Antimicrob Agents Chemother, 2013, 57 ( 8 ) :3640 - 3644.
7Matsushima H,Soyama A,Takatsuki M, et al. The outcomes of patients with severe hyperbilirubinemia following living donor liver transplantation[ J]. Dig Dis Sei,2013,58 ( 5 ) : 1410 - 1414.
8Kaplan M, Hammerman C. Association between neonatal hyperbilirubinemia and UDP- glucuronosyl transferase 1A1 gene polymorphisms[J]. Pediatr Int,2013,55(2) :259.
9Huang HC,Yang HI,Chang YH,et al. Model to predict hyperbiliru-binemia in healthy term and near-term newborns with exclusive breast feeding[J]. Pediatr Neonatol,2012,53 (6) :354 -358.
10Han SB, Kim GS,Choi SJ,et al. Liver transplantation using grafts of living donors with isolated unconjugated hyperbilirubinemia: a matched case-control study[J]. Transpl Int,2013,26(6) :623-630.
